Intrinsiqq
Bon Natural Life Ltd. logo

Bon Natural Life Ltd. Quality Score

BON

⊜ Compare
Quality21

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-1.6x

Negative earnings, no valuation support

Cash Flow Multiple
80/100
23.0x

20–25x, moderate cash flow premium

Revenue Growth
0/100
-14.5%

Below 2%, essentially flat

Cash Flow Growth
60/100
Just turned +

Recently turned FCF-positive, capex cycle finishing, CAGR not yet meaningful

Business Quality & Capital Allocation

Share Dilution
0/100
228.2%

Heavy dilution above 5%

Margin Trend
0/100
-30.8pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$6M

Net debt/FCF of 44.8x, high leverage

2022
$840861
$5.00M
2023
$112816
$4.00M
2024
$80466
$7.00M
2025
$6.00M
$12.0M
CashDebt
Return on Capital
0/100
-2.1%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Bon Natural Life (BON) quality: score, margins and returns

Bon Natural Life (BON) scores 21/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -8.7% operating margins and -2.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Bon Natural Life (BON) a high-quality business?+

Bon Natural Life scores 21 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -8.7% operating margin and a -2.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Bon Natural Life's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from BON's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Bon Natural Life scores well and where it falls behind.

What is Bon Natural Life's return on invested capital (ROIC)?+

Bon Natural Life earns about -2.1% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to BON's margins and growth on this scorecard to judge durability.

How profitable is Bon Natural Life?+

Bon Natural Life runs an operating margin of about -8.7% and a net margin of about -10.7%. Revenue has grown at roughly 0.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-K filed 23 Jan 2026, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 17 Apr 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with BON

CompareIntrinsic value
CHUCCharlie's Holdings Inc.
$0.10-11.65%10
CYANCyanotech Corporation
$0.45+0.00%0
CWLXFC21 Investments Inc.
No recent price8
MEHAFunctional Brands Inc.
$0.00-15.62%0
SNYRSynergy CHC Corp.
No recent price10
HYEXHealthy Extracts Inc.
$1.29+0.00%55
CBDYTarget Group Inc.
$0.00+0.00%8
PLSHPanacea Life Sciences Holdings, Inc.
$0.07-20.29%36

Spot a number that looks wrong? Check it in BON's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BON

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.